Correspondence.

Authors :: Miall, F.
Rye, A.
Fraser, M.
Hunter, A.
Snowden, J. A.
Corti, P.
Urdezo, C.
Tagliabue, A.
Volpe, A. Della
Annaloro, C.
Tagliaferri, E.
Balduzzi, A.
Hequet, O.
Dumontet, C.
Jaafario Corbin, A El
Salles, G.
Espinouse, D.
Arnaud, P.
Thieblemont, C.
Source :: Bone Marrow Transplantation; 3/15/2002, Vol. 29 Issue 6, p541, 4p
Publication Year :: 2002
Abstract: Presents updates on bone marrow transplantation as of March 2002. Information on the potential pathogenicity of human parainfluenza virus type 4 in post-hematopoietic stem cell transplants; Details on the possible role of defibrotide in treating thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation; Discussion on acute toxicities associated with autologous peripheral progenitor cell infusion in patients receiving high-dose chemotherapy.